M & A Attorneys At Rigrodsky & Long, P.A. Announce Investigation Of Possible Inadequately Priced Astex Pharmaceuticals, Inc. Buyout

WILMINGTON, Del.--(BUSINESS WIRE)--Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Astex Pharmaceuticals, Inc. (“Astex” or the “Company”) (NASDAQ GS: ASTX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Otsuka Pharmaceutical Co., Ltd. (“Otsuka”) in a transaction valued at approximately $886 million.